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Abstract 
Lysine-rich phosphorylated cystatin c1 (P-cystatin a) from newborn rat epidermis is a good substrate for epidermal transglutaminase (TGase) and 
also one of the component proteins of comified envelope in the stratum comeum. Since the filaggrin linker segment peptide was efficiently conjugated 
with Pcystatin a and was mediated by epidermal TGase in the presence of Ca*’ ions, filaggrin is a candidate for the glutamine-rich linkage protein 
to conjugate with lysine-rich P-cystatin a. A conjugated protein was formed by epidermal TGase in the activated condition with Ca*’ ions and 
dithiothreitol. In contrast, the conjugated protein was not formed under chelated conditions with EDTA. The conjugated protein reacted positively 
with anti-P-cystatin ok polyclonal antibody (PoAb). The conjugated protein and purified comified envelope showed an inhibitory effect against papain 
and cathepsin I+ but cathepsin B and H were not inhibited by these P-cystatin a conjugates. Although the component protein, P-cystatin cz itself, 
inhibited cathepsin H strongly, these conjugated proteins inhibited specifically the cathepsin L family. The amino acid composition of comified 
envelope protein and the conjugated protein of P-cystatin IZ and filaggrin linker segment peptide was not completely the same. The conjugated protein 
of P-cystatin cc and filaggrin linker segment peptide showed the same inhibitory properties against cysteine proteinases as the comified envelope. These 
findings suggest hat the linkage protein between P-cystatin a and filaggrin linker segment peptide may be considered a model of comified envelope, 
although skin comified envelope may be conjugated with some additional proteins. 
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1. Introduction 
We have previously reported that cystatin cx phos- 
phorylated by protein kinase C (P-cystatin cc) is located 
in keratohyalin granules of the stratum granulosum and 
also in the comified envelope of stratum comeum [l]. 
Cornified envelope is formed from specific substrates by 
epidermal transglutaminase (TGase) during the terminal 
differentiation of epidermal cells [2]. Since cystatin 01 
contains many lysine residues [3,4], it is a good substrate 
of epidermal TGase in vitro [5]. A suitable glutamine- 
rich protein or peptide to cross-link with P-cystatin a by 
epidermal TGase is necessary to form the cornified enve- 
lope [6]. Filaggrin, a component of comified envelope 
protein in the stratum comeum [7], is a glutamine-rich 
protein, particularly its linker segment peptide which has 
6 glutamine residues among the 26 amino acid residues 
[8]. Although it has been clarified by our group that 
*Corresponding author. 
Abbreviations: P-cystatin a, phosphorylated cystatin a; TGase, 
transglutaminase; PoAb, polyclonal antibody; SDS-PAGE, sodium do- 
decylsulfate polyacrylamide gel electrophoresis. 
P-cystatin c1 is a component protein of comified envelope 
[l], the glutamine-rich linkage protein has not been 
determined. Therefore, we propose the linkage reaction 
between P-cystatin a and filaggrin linker segment pep- 
tide by epidermal TGase as a model of comified enve- 
lope formation. Also inhibition of various cysteine pro- 
teinases by comified envelope and conjugated protein 
are examined. 
2. Materials and methods 
2.1. Materials 
Newborn Sprague-Dawley rats were purchased from SLC, Japan, 
Superose 12, Mono-Q and Superdex 200 columns and amuholines were 
obiained from Pha&nacia-LKB, Sweden. Gradient SDS-PAGE gel 
(15-25%) was ordered from Daiichi Pure Chemical Co. Ltd., Japan, 
and a protein assay kit was obtained from Bio-Rad, USA. PVDF 
membrane was purchased from Nippon Millipore Limited, Japan. 
Other chemicals, analytical grade, were purchased from commercial 
sources. 
2.2. Purification of P-cystatin a and formation of polyclonal antibody 
(PoAb) against P-cystatin a 
Newborn rat epidermis was separated with EDTA solution as de- 
scribed previously [9], and P-cystatin a was purified by isoelectric fo- 
cussing. Superose 12 gel filtration and Mono Q anion exchange column 
chromatography. This was then used to raise a PoAb. 
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2.3. Preparation of corntfied envelope 
Comified envelope was prepared as follows. Newborn rat stratum 
comeum was sonicated in 50 mM Tris-HCl (pH 9.0) containing 8 M 
urea and 10 mM 2-mercaptoethanol, stirred for 30 min and centrifuged 
at 15,000 ‘pm. After this procedure was repeated 3 times, the residue 
was rinsed with 50 mM Tris-HCl (pH 7.4) 5 times. The residue was 
rinsed with distilled water and lyophilized. 
2.4. Partial puriJication of epidermal TGase 
Cow snout epidermis was lyophilized and the powder was extracted 
and partially purified by the modified method of Buxman and Wuepper 
[lo] by anion-exchange chromatography and gel filtration. 
2.5. Synthesis offilaggrin linker segment peptide 
Filaggrin linker segment peptide, whose sequence was -Y-Y-Y-E-Q- 
E-H-S-E-E-E-S-D-S-Q-H-Q-H-G-H-Q-H-E-Q-Q-R- [8], was synthe- 
sized using a Shimadzu peptide synthesizer. 
2.6. Conjugation of P-cystatin a andfilaggrin linker segment peptide by 
epidermal TGase 
We examined the conjugation of P-cystatin a alone and with filaggrin 
linker segment peptide by epidermal TGase as follows: P-cystatin a 
(0.05 nmol) was incubated, alone and with filaggrin linker segment 
peptide (0.5 nmol), was incubated with epidermal TGase in the acti- 
vated condition containing 10 mM CaCl, and 10 mM dithiothreitol or 
in the chelated condition containing 10 mM EDTA. These samples were 
then treated with 1% SDS and 2-mercaptoethanol and subjected to 
SDS-PAGE. 
2.7. Immunoblotting analysis using anti-P-cystatin a PoAb 
The proteins in SDS-PAGE gel were transferred to PVDF mem- 
brane. The membrane was reacted with anti-P-cystatin a PoAb and 
then it was reacted with peroxidase-conjugated goat anti-rabbit IgG. 
The reactive proteins were stained with 3,3’-diaminobenzidine and 
HZ&. 
2.8. Collection of the conjugated protein 
The conjugated protein of P-cystatin a and filaggrin linker segment 
peptide formed by epidermal TGase was collected by Superdex 200 
column gel filtration. The amount of protein was determined utilizing 
the Bio-Rad protein assay kit. Bovine serum albumin was used as a 
standard protein for calibration. 
Fig. 1. SDS-gel electrophoresis profiles on the conjugated proteins by 
epidennal TGase between P-cystatin a and filaggrin linker segment 
peptide. (A) Immunoblotting analysis using anti-P-cystatin a PoAb; (B) 
Coomassie brilliant blue staining. (a,b) P-cystatin a with TGase; (cd) 
P-cystatin a and filaggrin linker segment peptide with TGase; (a$) 
Under activated conditions containing 10 mM CaCl* and 10 mM 2- 
mercaptoethanol; (b,d) Under chelated conditions containing 10 mM 
EDTA. Arrows and arrowheads indicate the conjugated protein 
formed and P-cystatin a, respectively. 
2.9. Inhibitory properties of corniJed envelope and the conjugated 
protein 
The inhibitory properties of comified envelope and the conjugated 
protein against cysteine proteinase activities were determined using 
MCA conjugated synthesized substrates. Because cornified envelope 
was not soluble, it was suspended in Tris-HCl buffer containing Brij-35. 
Papain, cathepsin B, H and L were used for inhibitory activity assay 
of comified envelope and the conjugated protein. Fluorescence was 
measured at excitation 370 nm and emission 460 nm [l 11. 
2.10. Amino acid composition of the conjugated protein 
The conjugated protein was subjected to reverse-phase column 
chromatography and its amino acid composition was determined using 
Derivatizer, Applied Biochemicals, USA. Comified envelope, which 
was prepared by the above method, was hydrolyzed in 6 N HCl for 24 h. 
Amino acid composition was also determined using Derivatizer. 
3. Results 
Conjugated proteins between P-cystatin 01 and filag- 
grin linker segment formed by epidermal TGase are 
shown in the SDS-gel electrophoresis pattern in Fig. 1. 
Two kinds of high molecular weights proteins conju- 
gated with P- cystatin 01 were formed by partially purified 
epidermal TGase under activated conditions. However, 
the yield was not enough, because of a small amount of 
contamination of glutamine-rich protein(s) in the par- 
tially purified epidermal TGase preparation were used as 
the glutamine-donor protein. Therefore, filaggrin linker 
segment peptide, one of the glutamine-rich peptides 
found in the epidermis, was synthesized using the 
method of Resing et al. [8]. In contrast, sufficient 
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Fig. 2. Inhibition of papam, cathepsm B, H and L by comified enve- 
lope. (A) Papain; (B) cathepsin L; (C) cathepsin B; (D) cathepsin H. 
Comified envelope is insoluble, therefore this is used as the suspension 
The amounts indicated are dry weight of comified envelope. 
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Fig. 3. Inhibition of papain, cathepsin B, H and L by the conjugated 
protein synthesized by epidermal TGase. (A) Papain; (B) cathepsin L, 
(C) cathepsin B; (D) cathepsin H. The amounts of proteins were assayed 
by Bio-Rad protein assay kit using bovine serum albumin as a standard 
protein. 
amounts of the conjugated protein were synthesized by 
addition of the filaggrin linker segment peptide under the 
same conditions. These conjugated proteins reacted pos- 
itively with anti-P-cystatin Q PoAb by immunoblotting 
as shown in Fig. 1A and also with anti-filaggrin PoAb 
(data not shown). These products, however, were not 
Table 1 
Comparison of amino acid compositions of the conjugated protein of 
P-cystatin a and filaggrin linker segment peptide, P-cystatin a and 
cornified envelope 
Amino acid 
Asp 
Glu 
Ser 
Gly 
His 
Arg 
Thr 
Ala 
Pro 
Tyr 
Val 
Met 
Cys 
Ile 
Leu 
Phe 
Lvs 
Conjugated 
protein 
3.6 
8.7 
8.1 
21.6 
4.5 
6.5 
5.2 
7.5 
4.4 
2.3 
6.3 
1.8 
0.8 
5.0 
7.8 
5.6 
10.3 
P-Cystatin d[ 
12.0 
14.3 
3.6 
10.0 
1.2 
3.2 
7.3 
4.5 
3.3 
2.9 
8.0 
2.6 
0 
2.2 
8.7 
4.0 
13.7 
Comified 
envelope 
2.3 
7.7 
20.2 
37.3 
0.7 
2.4 
2.3 
2.6 
4.6 
3.0 
2.9 
0.5 
5.4 
1.3 
2.2 
1.4 
3.3 
formed under chelated conditions. The purified cornified 
envelope (dry weight of cornified envelope: 0 to 400 pug) 
showed strong inhibition against papain and cathepsin 
L, but not against cathepsin B and H as shown in Fig. 
2, while P-cystatin a itself inhibited cathepsin H consid- 
erably. The inhibitory profile of the enzymatic conju- 
gated proteins between P-cystatin c1 and filaggrin linker 
segment peptide are presented in Fig. 3. The conjugated 
protein strongly inhibited the activities of papain and 
cathepsin L, and the inhibition profile was the same as 
that of the cornified envelope. However, since the enzy- 
matic synthesized proteins were water soluble, the in- 
hibitory intensity was much stronger than that of corni- 
fied envelope. The amino acid composition of the conju- 
gated protein is compared with those of P-cystatin c1 and 
cornified envelope in Table 1. 
4. Discussion 
We have previously reported that P-cystatin a is a 
substrate of epidermal TGase and a component protein 
of cornified envelope [l]. Cornified envelope seems to be 
formed by a cross-linking reaction of epidermal TGase 
between P-cystatin 01 and glutamine-rich protein(s). Fi- 
laggrin [7], involucrin [12], loricrin [13] and cystine-rich 
protein [14] in the epidermis have been reported as suit- 
able substrates of TGase. When P-cystatin a was reacted 
with a partially purified epidermal TGase, a small 
amount of the conjugated proteins was formed. This 
high molecular weight protein may be formed from P- 
cystatin 01 and an unknown glutamin-rich protein con- 
taminating in the partially purified epidermal TGase 
fraction. The synthesized filaggrin linker segment pep- 
tide was used as a substrate of glutamine-rich peptide to 
conjugate with P-cystatin 01 by epidermal TGase. The 
same high molecular weight conjugated proteins were 
formed as when filaggrin linker segment peptide was not 
added. Comified envelope and the conjugated protein 
inhibit the activities of papain and cathepsin L, but not 
the activities of cathepsin B and H. Although the amino 
acid compositions between the conjugated protein 
formed by epidermal TGase in vitro and natural comi- 
fied envelope were not the same, they became similar 
when the amino acid composition of conjugated protein 
was plus that of loricrin [13] which was major protein of 
comified envelope [151 as shown in Fig. 4. It is speculated 
that natural comified envelope could be conjugated with 
protein(s) other than filaggrin, such as loricrin. Further- 
more, the conjugated protein showed the same inhibitory 
properties as natural cornified envelope. P-cystatin a in- 
hibited cathepsin H activity to the same degree as that 
cathepsin L activity, but natural comified envelope and 
conjugated protein did not inhibit cathepsin H activity. 
Therefore, the conjugation of P-cystatin a and filaggrin 
linker segment peptide could be considered a model of 
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Fig. 4. Comparison of the amino acid profiles of comified envelope and the sum of those of the conjugated protein and loricrin. Closed circles and 
open circles indicate the amino acid composition of cornified envelope and that of sum of the conjugated protein and loricrin, respectively. 
cornified envelope formation. Korant et al. reported that 
egg white cystatin inhibited cysteine proteinase of pi- 
corna virus and processing of the virus precursor pro- 
teins [ 16,171. Cornified envelope and conjugated protein 
in the stratum corneum may act as a barrier by inhibition 
of cysteine proteinases of bacteria and viruses. 
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